Page 7 - Nasdaq Podd News Today

Bessemer Group Inc. boosted its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 37.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 315 shares of the medical instruments supplier’s stock after purchasing an additional 85 shares during […]

Citigroup upgraded shares of Insulet (NASDAQ:PODD – Free Report) from a neutral rating to a buy rating in a report released on Monday, Marketbeat Ratings reports. They currently have $265.00 price target on the medical instruments supplier’s stock, down from their previous price target of $273.00. A number of other brokerages also recently commented on […]

Citigroup upgraded shares of Insulet (NASDAQ:PODD – Free Report) from a neutral rating to a buy rating in a report released on Monday morning, MarketBeat Ratings reports. They currently have $265.00 price objective on the medical instruments supplier’s stock, down from their previous price objective of $273.00. PODD has been the subject of several other […]

Gateway Advisory LLC acquired a new stake in Insulet Co. (NASDAQ:PODD – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 549,887 shares of the medical instruments supplier’s stock, valued at approximately $550,000. Other large investors also recently bought […]

Equities researchers at StockNews.com began coverage on shares of Insulet (NASDAQ:PODD – Get Free Report) in a note issued to investors on Thursday. The firm set a “hold” rating on the medical instruments supplier’s stock. A number of other brokerages have also commented on PODD. Wells Fargo & Company cut their price target on Insulet […]

StockNews.com started coverage on shares of Insulet (NASDAQ:PODD – Free Report) in a research note released on Thursday. The brokerage issued a hold rating on the medical instruments supplier’s stock. PODD has been the topic of several other reports. JPMorgan Chase & Co. cut their price objective on shares of Insulet from $365.00 to $325.00 […]

Triodos Investment Management BV reduced its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 20.0% during the 1st quarter, Holdings Channel reports. The firm owned 40,000 shares of the medical instruments supplier’s stock after selling 10,000 shares during the quarter. Triodos Investment Management BV’s holdings in Insulet were worth $12,758,000 at the end of […]

Clearstead Advisors LLC boosted its position in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 559.1% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 145 shares of the medical instruments supplier’s stock after purchasing an additional 123 shares during the quarter. Clearstead […]

Y Intercept Hong Kong Ltd cut its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 14.4% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,038 shares of the medical instruments supplier’s stock after selling 343 shares during the quarter. Y Intercept […]

California State Teachers Retirement System lowered its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 0.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 118,611 shares of the medical instruments supplier’s stock after selling 1,045 shares during the […]